Basal keratinocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific by Giannoudis, A et al.
Human papillomaviruses (HPV) are members of a group of small,
double-stranded DNA viruses which are causally associated with
anogenital carcinomas and particularly with cervical carcinoma
(Arends et al, 1990). The mechanisms by which the HPVs func-
tion in malignant progression appear predominantly to involve the
activity of the two viral oncoproteins, E6 and E7. However, the
development of invasive carcinoma is a multistep process
involving the accumulation of a number of mutational events.
Alterations to oncogenes and/or tumour suppressor genes, as well
as parameters such as smoking and other viral infections appear to
be required in parallel to infection (Herrington, 1995). In vitro
studies have shown that HPV can induce genetic abnormalities
including chromosomal imbalances in stably transfected cells
(Hashida and Yasumoto, 1991; White et al, 1994; Steenbergen et
al, 1996; Salinas-Toldo et al, 1997). However, stable transfection
is associated with viral integration. Consequently, early genetic
events related to productive infection cannot be studied by this
approach. Moreover, although chromosome abnormalities have
long been known to occur in invasive cervical carcinoma (Atkin,
1997), it has not been established at which stage of in vivo trans-
formation these changes occur.
A preliminary study from our group showed that numerical
chromosomal abnormalities occur in some HPV-infected low-
grade cervical squamous intra-epithelial lesions (SILs) (Southern
et al, 1997). In this study, we have extended this to a large series of
low-grade SILs and have analysed a broader range of chromo-
somes by including chromosomes 4, 6 and 10 which have been
reported to be abnormal in in vitro studies of HPV-induced immor-
talization (Steenbergen et al, 1996; Salinas-Toldo et al, 1997).
Interphase cytogenetics showed tetrasomy with all of the chromo-
somes in 17/46 lesions infected with high-risk HPVs and 23/83
lesions infected with intermediate-risk HPVs: this difference was
not statistically significant (c2 = 1.18, df = 1, P > 0.05). In all
lesions, tetrasomy was present throughout the thickness of the
epithelium, including the basal layer. None of the lesions infected
with low-risk types or the 15 normal cervices showed any numer-
ical chromosomal abnormality. Basal keratinocyte tetrasomy was
therefore restricted to infection with high- and intermediate-risk
HPVs. Although infection with a wide range of HPV types was
identified, the presence of tetrasomy was not type-specific.
MATERIALS AND METHODS
Tissue specimens
One hundred and seventy-nine low-grade squamous intra-epithe-
lial lesions (SILs) and 15 normal cervices were identified from the
diagnostic files of the Royal Liverpool University Hospital. The
low-grade lesions comprised condylomata acuminata (n = 27), flat
condylomata (n = 53) and cervical intra-epithelial neoplasia (CIN)
grade 1 (n = 99). All of the diagnoses were confirmed by CSH.
DNA extraction
Three 5-mm formalin-fixed, paraffin sections of cervical biopsy
material were dewaxed in xylene (2 ´ 5 min) followed by 96%
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ethanol (2 ´ 5 min), then pelleted, air-dried and incubated
overnight at 42°C with 200 mg ml–1 proteinase K (Boehringer
Mannheim) in 200 mM Tris–HCI pH 8.0, 1 mM EDTA. The digest
was heated to 95°C for 20 min to stop enzymatic activity,
centrifuged and the supernatant used for polymerase chain
reaction (PCR). The quality of the DNA was assessed by ampli-
fying a 209 bp b-globin fragment using PCO3 and PCO5 primers
(Jacobs et al, 1995).
HPV typing by PCR
Ten to 15 ml of the extracted DNA was used in a 50 ml PCR
reaction containing 50 mM potassium chloride, 10 mM Tris–HCI
(pH 8.3), 200 mM of each dNTP, 3.5 mM magnesium chloride, 1 U
of  Taq DNA polymerase and 50 pmol each of the consensus
GP5+/GP6+ primers. The primers amplify a fragment of 140–
150 bp (depending on HPV type) from the L1 gene. PCR condi-
tions comprised an initial denaturation step at 95°C for 4 min
followed by 40 cycles of: denaturation at 94°C for 1 min,
annealing at 40°C for 2 min, extension at 72°C for 1.5 min,
followed by a final extension step at 72°C for 7 min to ensure
complete extension of the amplified DNA. Ten microlitres of the
PCR product were analysed on a 1.7% agarose gel stained with
ethidium bromide. The gel was then denatured and blotted on to
positively charged nylon (Southern blot). The remaining PCR
product was diluted 1:10 and denatured for 10 min at 95°C. One
microlitre of denatured DNA was then applied on to individual
nylon memranes and placed under UV light for 3 min, followed by
baking at 80°C for 1 h.
Membranes were placed into pre-hybridization buffer (0.02%
sodium dodecyl sulphate (SDS), 1% blocking reagent (Boehringer
Mannheim) in 2 ´ standerd saline citrate (SSC) for 1 h at 55°C and
hybridized overnight at the same temperature using individual 5¢
digoxigenin-labelled oligonucleotide probes specific for low-risk
(HPV 6, 11, 40, 42, 43 and 44), intermediate-risk (HPV 31, 33, 35,
39, 51, 52, 58, 59, 66 and 68) and high-risk (HPV 16, 18, 45, and
56) HPV types (Jacobs et al, 1995). Hybridization was followed
by washes in post-hybridization buffer (0.1% SDS in 2 ´ SSC) 
3 ´ 10 min at 55°C and in blocking solution (0.5% Tween-20, 1%
blocking reagent in 0.1 M Tris–HCl, pH 7.5) for 45 min at room
temperature. Signal was detected with anti-digoxigenin–alkaline
phosphatase conjugate diluted 1:5000 in blocking solution for 
30 min and developed using nitroblue tetrazolium/bromo-
chloroindolyl phosphate (NBT/BCIP).
HPV localization by in situ hybridization
Tissue sections were dewaxed in xylene, rehydrated through graded
alcohols and washed in Molecular Biology Grade (MBG) water.
Sections were digested with 0.5 mg ml–1 proteinase K in 0.1 M
Tris–HCl pH 7.6 for 20 min at 37°C and hybridized with a mixture
of nick-translated digoxigenin labelled probes derived from HPV 6,
11, 16, 18, 31, 33 plasmid clones in 50% formamide, 20 ´ SSC,
10% dextran sulphate, under low stringency conditions to allow
hybridization to a wide range of HPV types (Southern et al, 1997).
When multiple infection was identified by PCR in lesions showing
chromosome abnormalities, in situ hybridization with the appro-
priate individual probes was carried out to establish the morpho-
logical localization of the individual HPV types (i.e. HPV 6, 11, 16,
18, 31, 35, 45, 51, 56 and 66; see Results). All of the probes used
for in situ hybridization consisted of the cloned whole viral genome
(see Southern et al (1997) for details of the source of each clone).
Interphase cytogenetic analysis
Tissue sections were dewaxed in xylene, rehydrated through
graded alcohols, washed in MBG water and immersed in 1 M
sodium thiocyanate at 80°C for 10 min. Sections were digested
with 4 mg ml–1 of pepsin (Sigma) in 0.2 M hydrochloric acid for 
20 min at 37°C, followed by washes with water and air-drying.
Chromosome probes (1, 3, 4, 6, 10, 11, 17, 18 X) (Oncor) at a
concentration of 1 ng ml–1 in 60% formamide, 2 ´ SSC, 10%
dextran sulphate and 1 mg ml–1 sheared salmon sperm DNA were
applied to the dry sections. The probe and tissue were denatured at
80°C for 8 min and hybridized overnight in a 37°C oven, as previ-
ously described (Southern and Herrington, 1996). These probes
allow the assessment of centromere number per cell nucleus but do
not provide information about non-centromeric chromosomal
areas. The number of signals per nucleus was counted in a total of
200 nuclei from each lesion following the rules previously estab-
lished for signal counting. The presence of three and four signals
per nucleus in > 10% of nuclei determines trisomic and tetrasomic
cell populations respectively as previously validated (Southern
and Herrington, 1996, 1997).
RESULTS
HPV typing and localization of infection
HPV typing by PCR
All of the tissues examined were positive for b-globin by PCR
indicating the presence of adequate DNA for further analysis. One
hundred and seventy-three of 179 specimens were found to be
HPV-positive. Sixty-two lesions contained low-risk HPVs (HPV 6
(n = 30), 11 (n = 19), 40 (n = 1), 42 (n = 5), 43 (n = 6), 44 (n = 1)),
46 lesions contained high-risk HPVs (HPV 16 (n = 21), 18 (n =
13), 45 (n = 4), 56 (n = 8)) and 83 lesions contained intermediate-
risk HPVs (HPV 30 (n = 1), 31 (n = 7), 33 (n = 3), 35 (n = 16), 39
(n = 3), 51 (n = 12), 52 (n = 3), 58 (n = 14), 59 (n = 3), 66 (n = 19),
68 (n = 2)). HPV 30 and an unknown type with homology to
HPV43 (77%), thus classified as low risk, were identified by DNA
sequencing. Multiple types were identified in 17 cases (6/11, 6/16,
6/18, 6/31, 6/35 (n = 2), 6/66, 11/18, 11/66, 16/56, 18/31, 18/56,
35/51, 35/66, 45/51, 51/66, and 59/51/42) and were included indi-
vidually in the above HPV numbers. The 15 normal cervices were
HPV-negative.
In situ hybridization
Six of the 173 specimens that were HPV-positive by PCR were
negative by in situ hybridization. All the other specimens were
positive with both methods allowing morphological localization of
the infection to be established (Figure 1). The six non-infected
cases and the 15 normal cervices were negative with both
methods. In situ hybridization also allowed the localization of
individual HPV types to different morphological areas in the nine
biopsies in which both multiple HPV types and chromosome
abnormalities were identified: this allowed accurate karyotypic
assessment of these areas.426 A Giannoudis et al
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Figure 1 A representative example of in situ hybridization of CIN 1 lesions using a cocktail of HPV probes. The arrows indicate HPV-infected cells. HPV typing
by GP5+/GP6+ PCR revealed infection with HPV 66 in A and HPV 18 in B.
A
B
Figure 2 Representative examples of interphase cytogenetic analysis using a centromeric probe for chromosome 1. Note the presence of two chromosome 1
signals in both epithelial (arrows) and stromal (arrowhead) cell nuclei in A. This contrasts with tetrasomy (four chromosome 1 signals) in epithelial cell nuclei
(arrows), including basal keratinocytes (arrowhead), despite disomy of stromal cells (grey arrow) in B. The approximate position of the basement membrane is
shown as a dotted line in A.Chromosome analysis
Correlation of tetrasomy with HPV types
Tetrasomy was present with all nine chromosomal probes in a total
of 40 lesions (Figure 2). In 36 lesions, tetrasomy persisted
throughout the whole epithelial thickness, extending from basal to
superficial epithelial cells. In four cases, initial sections showed
apparently focal tetrasomy in suprabasal cells. Further sections
were analysed from these lesions and tetrasomy of basal cells was
identified indicating that the apparent suprabasal localisation of
tetrasomy in the initial sections was due to cross-cutting artefact in
small lesions. All the other lesions, including the normal control
tissues were disomic, showing three signals in 0.5–2.5% of nuclei
and four signals in 0.5%.
Overall, of the 46 lesions infected with high-risk HPVs, 17
showed basal cell tetrasomy and, of the 83 lesions infected with
intermediate-risk HPVs, 23 showed basal cell tetrasomy (Figure
2). The difference between these two groups is not statistically
significant (c2 = 1.18, df = 1, P > 0.05). All of the 62 lesions
infected with low-risk HPVs were disomic. These figures include
the multiple infections. Nine lesions showing basal cell tetrasomy
were infected with more than one HPV type. In order to identify
which HPV type was present in the area showing chromosome
abnormality, in situ hybridization was performed using digoxi-
genin-labelled probes specific for each type. The results are
summarized in Table 1.
Correlation of the interphase cytogenetic and HPV in situ
hybridization data demonstrated that, although the chromosome
abnormalities were confined to HPV-infected areas, they were not
present throughout the HPV-infected area.
DISCUSSION
In this study, we have demonstrated, in a series of 179 low-grade
SILs of the cervix, that basal keratinocyte tetrasomy is associated
with infection with high- and intermediate- but not low-risk HPV
types. This is consistent with the fact that the E6 and E7 proteins of
high-risk HPVs interact with components of the cell cycle control
machinery, including p53, pRb and p21 (Slebos et al, 
1994; Galloway and McDougall, 1996; Xiong et al, 1996).
Endoreduplication has been described in association with the abro-
gation of p21 function as a result of E7 binding (Stewart et al,
1999). Similarly, duplication of cellular DNA content as identified
by flow cytometry has been induced by E6, E7 and E2 protein
expression, particularly in the presence of mitotic spindle
inhibitors (di Leonardo et al, 1997; Frattini et al, 1997). These in
vitro findings are consistent with the observation that mitotic
checkpoint abnormalities can be induced by both E6 and E7
proteins (Steinmann et al, 1994; Thomas and Laimans, 1998). In
addition, it has been shown that the absence or loss of function of
wild-type p53 from mouse embryonic fibroblasts results in
multiple copies of functionally competent centrosomes (Fukasawa
et al, 1996). However, our finding of tetrasomy indicates not only
chromosome re-duplication, consistent with endo-reduplication,
but also centromere separation, implying that the mechanism by
which cellular DNA is reduplicated involves separation of sister
chromatids.
Although tetrasomy was only found in lesions infected with
high- and intermediate-risk HPVs, it was not type-specific and
there was no significant difference in the frequency of tetrasomy
in lesions infected with intermediate-risk, by comparison with
high-risk types. Whilst this observation casts some doubt over the
distinction between high- and intermediate-risk HPVs, these two
groups were defined on the basis of clinical risk association
(Lorincz et al, 1992). These clinical associations are likely to be
dependent upon a wide range of biological properties of the indi-
vidual viral types and hence retention of the distinction between
high- and intermediate-risk HPVs may be useful in identifying
factors which are important in neoplastic transformation by these
viruses. A wide range of HPV types was identified in the lesions
analysed and tetrasomy was present in lesions infected with HPVs
16, 18, 31, 33, 35, 39, 51, 52, 56, 58 and 66. However, these viral
types were also present in lesions showing no numerical chromo-
somal abnormality. In addition, HPV in situ hybridization demon-
strated that basal cell tetrasomy was not present throughout the
HPV-infected areas in any of the lesions showing tetrasomy.
These two observations indicate that other factors are involved in
determining whether basal cell tetrasomy will develop. Possible
viral factors include: the level of viral early gene expression and
its relationship to keratinocyte differentiation; the presence of
different HPV-type variants; and persistence of viral infection,
which has been shown to be an important factor in determining
progression of intra-epithelial lesions (Remminck et al, 1995).
Furthermore, cellular factors such as activation of oncogenes,
inactivation of tumour suppressor genes, abnormalities of cell
cycle regulators, smoking, immunosuppression and the presence
of other infectious agents may also be involved (Herrington,
1995; Howley, 1996).
The morphological location of the numerical chromosomal
abnormalities identified in this study suggests that the induction of
tetrasomy is more likely to be related to initial viral early gene
expression than to viral DNA replication. Tetrasomy was present
in the basal and suprabasal cell layer and, in the majority of
lesions, extends throughout the epithelium indicating persistence
despite squamous cell differentiation. In four lesions, tetrasomy
was present only in basal and suprabasal keratinocytes and did not
extend to the superficial layers. This observation suggests that
tetrasomy begins in the proliferating part of the epithelium and
implies that this phenomenon is not directly related to viral DNA
replication which occurs in the intermediate and superficial layers
of the epithelium (Howley, 1996). Moreover, as it is known that
the E6 and E7 genes are expressed in basal epithelial cells
(Higgins et al, 1992; Nilsson et al, 1996), it is consistent with in
vitro evidence that the E6 and E7 proteins can induce DNA re-
replication and, after more prolonged exposure, chromosome
abnormalities in transfected cells (Xiong et al, 1996).
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Table 1 Association of numerical chromosomal abnormalities with HPV
types. For the multiple infections showing tetrasomy, the HPV type present in
the tetrasomic area is underlined
HPV type Disomy Basal keratinocyte tetrasomy
Low risk 51 0
Intermediate risk 51 17a
High risk 23 14b
Multiple infections 8c 9d
aLesions containing HPV 31 (n = 2), 33 (n = 2), 35 (n = 1), 39 (n = 1), 52 
(n = 1), 58 (n = 6), 66 (n = 4). bLesions containing HPV 16 (n = 7), 18 (n = 6),
56 (n = 1). cLesions containing HPV 6&11; 51&66; 35&66; 6&35; 6&31;
11&18; 6&18; 42,51&59. dLesions containing HPV 6&66; 35&51; 18&56;
45&51; 16&56; 11&66; 6&35; 18&31; 6&16.428 A Giannoudis et al
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In conclusion, basal cell tetrasomy occurs in approximately
31% of low-grade cervical SILs infected with high- and 
intermediate-risk HPVs but not in those infected with low-risk
HPVs. Tetrasomy is not type-specific and is not always present
throughout the HPV-infected epithelium. Further investigation of
this phenomenon will provide important information regarding the
mechanisms by which HPVs interfere with cell cycle control.
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